WELL's Subsidiary Wisp Launches Comprehensive Weight Care Vertical Inclusive of GLP-1 Medications to Support Women Struggling with Hormonal Imbalances
- Wisp debuts its first-ever exclusive over-the-counter weight-loss supplement, designed to promote women's metabolic health.
- Wisp introduces personalized, online consultations with access to four weight care solutions, including GLP-1 medications, to support women struggling with hormonal conditions such as perimenopause, menopause, Polycystic Ovary Syndrome (PCOS), and endometriosis.
- With over 1.2 million patients, Wisp Now Also Bolsters its Menopause Solutions, Empowering Women Through All Major Stages of Their Healthcare Journey
Through this launch, Wisp introduces personalized, online consultations with access to four weight care solutions, including GLP-1 medications, to support women struggling with hormonal conditions such as perimenopause, menopause, Polycystic Ovary Syndrome (PCOS), and endometriosis. Additionally, Wisp debuts its first-ever exclusive over-the-counter weight care capsules, designed to promote women's metabolic health.
"Wisp is committed to providing sustainable support for women's weight loss journeys, addressing a critical yet overlooked aspect of women's health," said
"The launch of Wisp's weight care vertical taps into the transformative potential of GLP-1 therapies," said
Starting today, Wisp offers GLP-1 medications and supplements via pharmacy pickup or free, discreet delivery, following an online health consultation with a licensed provider. The program also includes educational content and monthly check-ins to ensure effective support throughout the patient's journey. Wisp's weight care program includes:
- Semaglutide (FDA-approved Wegovy®): Subcutaneous injectable medication
- Compounded Semaglutide: Subcutaneous and sublingual options
- Metabolic Support & GLP-1 Boost Capsules: Natural supplement with key ingredients such as:
- Eriomin®: Supports insulin function and healthy glucose levels
- Actiz!ng™ (Black Ginger Extract): Boosts calorie burn and reduces abdominal fat
- GlucoVantage® Dihydroberberine: Aids in body composition and blood sugar management
- PoZibio™ (Lactobacillus paracasei): Promotes gut health and metabolic function
In tandem with this launch, Wisp strengthens its menopause solutions, addressing the healthcare gap for the over 2 million women experiencing menopause annually. New offerings include Estriol Face Cream and hormone replacement therapies such as Transdermal Estradiol Patches, Oral Micronized Progesterone Capsules, and Provera Tablets.
These initiatives reflect Wisp's commitment to providing affordable, inclusive healthcare for women, complementing WELL's strategic vision of expanding access to high-quality care. Wisp's upcoming plans also include new at-home diagnostics and treatment options in STI, fertility, menopause, and weight care categories, further solidifying its leadership in digital women's health.
For more information about Wisp, visit www.hellowisp.com.
About
WELL's mission is to tech-enable healthcare providers. We do this by developing the best technologies, services, and support available, which ensures healthcare providers are empowered to positively impact patient outcomes. WELL's comprehensive healthcare and digital platform includes extensive front and back-office management software applications that help physicians run and secure their practices. WELL's solutions enable more than 37,000 healthcare providers between the US and
View original content to download multimedia:https://www.prnewswire.com/news-releases/wells-subsidiary-wisp-launches-comprehensive-weight-care-vertical-inclusive-of-glp-1-medications-to-support-women-struggling-with-hormonal-imbalances-302278979.html
SOURCE